SciClone Pharma (SCLN) Tops Q1 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi strike on Saudi airport kills 12, worst attack on kingdom in a decade
- US consumer sentiment near record low as frustration over economy mounts
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
SciClone Reports First Quarter 2015 Financial Results
May 11, 2015 4:01 PM EDTFOSTER CITY, CA -- (Marketwired) -- 05/11/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended March 31, 2015.
Revenues: In the first quarter 2015, SciClone reported revenues of $33.6 million, compared to $26.6 million for the same period in 2014. GAAP Diluted EPS: In the first quarter 2015, SciClone reported GAAP diluted earnings per share of $0.17, compared to $0.08 for the same period in 2014. Non-GAAP Diluted EPS: In the first quarter 2015, SciClone reported non-GAAP diluted earnings per share of $0.19, compared to $0.09 for the same period... More


